Approval · Notice of Compliance 38340 · 2026
NESINA: Notice of Compliance 38340
Issued September 23, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38340
- Date
- September 23, 2026
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NESINA | Not yet assigned | — |
Medicinal ingredients
- ALOGLIPTIN BENZOATE 6.25 MG per TAB
- ALOGLIPTIN BENZOATE 12.5 MG per TAB
- ALOGLIPTIN BENZOATE 25 MG per TAB